Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home    

Healthcare Market Research Reports

PRODUCT TITLE PUBLISHED
Dichloroacetamide derivatives Dichloroacetamide derivatives
Dichloroacetamide derivatives and its peer markets - Agents against leishmaniasis and trypanosomiasis,
Upcoming
Arsenic compounds Arsenic compounds
Arsenic compounds and its peer markets - Other agents against amoebiasis and other protozoal diseases,
Upcoming
Agents against amoebiasis and other protozoal diseases Agents against amoebiasis and other protozoal diseases
Agents against amoebiasis and other protozoal diseases and its peer markets - Wireless Health,
Upcoming
Antimalarials Antimalarials
Antimalarials and its peer markets - Chromatography,
Upcoming
Agents against leishmaniasis and trypanosomiasis Agents against leishmaniasis and trypanosomiasis
Agents against leishmaniasis and trypanosomiasis and its peer markets - Antimalarials,
Upcoming
Antitrematodals Antitrematodals
Antitrematodals and its peer markets - Healthcare IT outsourcing,
Upcoming
Antinematodal agents Antinematodal agents
Antinematodal agents and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Anticestodals Anticestodals
Anticestodals and its peer markets - Antinematodal agents,
Upcoming
Ectoparasiticides, incl. scabicides Ectoparasiticides, incl. scabicides
Ectoparasiticides, incl. scabicides and its peer markets - E-Clinical Trial Solutions,
Upcoming
Insecticides and repellents Insecticides and repellents
Insecticides and repellents and its peer markets - Ectoparasiticides, incl. scabicides,
Upcoming
Decongestants and other nasal preparations for topical use Decongestants and other nasal preparations for topical use
Decongestants and other nasal preparations for topical use and its peer markets - Proteomics,
Upcoming
Nasal decongestants for systemic use Nasal decongestants for systemic use
Nasal decongestants for systemic use and its peer markets - Proteomics,
Upcoming
Adrenergics, inhalants Adrenergics, inhalants
Adrenergics, inhalants and its peer markets - Clinical Trial Management Systems (CTMS),
Upcoming
Adrenergics for systemic use Adrenergics for systemic use
Adrenergics for systemic use and its peer markets - Wireless Health,
Upcoming
Expectorants, excl. combinations with cough suppressants Expectorants, excl. combinations with cough suppressants
Expectorants, excl. combinations with cough suppressants and its peer markets - Next Generation Sequencing (NGS),
Upcoming
Cough suppressants, excl. combinations with expectorants Cough suppressants, excl. combinations with expectorants
Cough suppressants, excl. combinations with expectorants and its peer markets - Wireless Health,
Upcoming
Cough suppressants and expectorants, combinations Cough suppressants and expectorants, combinations
Cough suppressants and expectorants, combinations and its peer markets - Healthcare IT outsourcing,
Upcoming
Aminoalkyl ethers Aminoalkyl ethers
Aminoalkyl ethers and its peer markets - E-Clinical Trial Solutions,
Upcoming
Substituted alkylamines Substituted alkylamines
Substituted alkylamines and its peer markets - Phenothiazine derivatives,
Upcoming
Substituted ethylene diamines Substituted ethylene diamines
Substituted ethylene diamines and its peer markets - Immunoassay, Wireless...
Upcoming
2983 reports | Show
Connect With Us
US/CAN : +1-888-502-0539